Celon Pharma S.A. Logo

Celon Pharma S.A.

An integrated pharmaceutical company researching and manufacturing modern drugs.

CLN | WAR

Overview

Corporate Details

ISIN(s):
PLCLNPH00015 (+3 more)
LEI:
259400Q0ERJT0NC5DT24
Country:
Poland
Address:
KAZUŃ NOWY MARYMONCKA 15, 05-152 KAZUŃ NOWY

Description

Celon Pharma S.A. is an integrated pharmaceutical company that conducts advanced research and manufactures modern drugs. The company is engaged in the development, production, distribution, and marketing of therapeutic solutions. Its primary focus is on developing treatments for cancers, neurological diseases, diabetes, and other metabolic disorders. As a marketing authorization holder, Celon Pharma manages the full product lifecycle, from scientific research and development to commercialization, aiming to improve patient health and quality of life.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-19 17:13
Raport 3 kwartał 2025
Polish 2.3 MB
2025-10-10 15:36
Statut - tekst jednolity
Polish 405.4 KB
2025-10-10 15:36
Rejestracja zmiany Statutu Spółki - Content (PL)
Polish 1.7 KB
2025-10-03 17:06
Zawarcie przez spółkę zależną umowy z generalnym wykonawcą inwestycji - Content…
Polish 2.7 KB
2025-10-02 17:55
Podsumowanie spotkania z Food and Drug Administration, (FDA) typu B dla CPL'36…
English 3.4 KB
2025-10-02 17:55
Podsumowanie spotkania z Food and Drug Administration, (FDA) typu B dla CPL'36…
Polish 3.2 KB
2025-09-17 17:55
Raport z przeglądu
Polish 218.2 KB
2025-09-17 17:55
Raport z przeglądu
Polish 437.5 KB
2025-09-17 17:55
Sprawozdanie z działalności Zarządu
Polish 953.2 KB
2025-09-17 17:55
Sprawozdanie finansowe H12025
Polish 1.6 MB
2025-09-11 11:12
Aktualizacja informacji dotyczącej przekazywania raportów okresowych w 2025 rok…
Polish 1.9 KB
2025-08-04 15:16
Uzgodnienie z Europejskim Bankiem Odbudowy i Rozwoju głównych warunków udzielen…
Polish 1.5 KB
2025-07-16 21:15
zal01_TCM_Celon_Notification_Form.pdf
English 89.7 KB
2025-07-16 21:15
Otrzymanie zawiadomienia o przekroczeniu progu 5% udziału w ogólnej liczbie gło…
Polish 1.1 KB
2025-06-26 21:39
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 888 bytes

Automate Your Workflow. Get a real-time feed of all Celon Pharma S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Celon Pharma S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Celon Pharma S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.